MSB 8.43% $1.35 mesoblast limited

Japanese Market participants, page-25

  1. 196 Posts.
    lightbulb Created with Sketch. 141
    Allow me to answer Aastik, Regenerative medicine has been moving ahead for 15 yrs
    Big money has been keeping it back. We're at a point of critical mass . Many phase 3 trials reporting . Overwhelming evidence of efficacy among hundreds of trials .
    Stocks are priced low to make favourable deals ..which by the way have not yet happened. No cheap deals done yet in the regen med sector.
    So who's the idiot Investors?
    This message does not go out to you because you are a paid schill, here to keep the price down and hide the naked shorting.
    My theory is Big pharma knows this is unstoppable but this manipulation will allow them to make a sweet deal.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.